| Industry | 科学研究和技术服务业 | ||||||||||||||||||||||||
| Company Introduction | 公司是一家同时提供药学研究和临床研究服务的综合型 CRO 企业，通过合同形式为医药企业和其他医药研发机构提供专业化医药研发外包服务。在药学研究领域，公司主要为客户提供仿制药开发、一致性评价服务，而在临床研究领域，则主要提供生物等效性研究服务。其中，生物等效性研究是公司的核心业务，具有较高的市场地位。公司自成立以来，荣获了国家高新技术企业、中国医药外包公司20强、中国医药守法诚信企业、合肥高新区瞪羚企业、安徽省企业技术中心、安徽省专精特新中小企业等多个荣誉。 | ||||||||||||||||||||||||
| Main Business | 公司是一家同时提供药学研究和临床研究服务的综合型CRO企业，通过合同形式为医药企业和其他医药研发机构提供专业化医药研发外包服务。 | ||||||||||||||||||||||||
| Legal Representative | 陶春蕾 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 刘妹 | ||||||||||||||||||||||||
| Solicitors | 安徽承义律师事务所 | ||||||||||||||||||||||||
| Auditors | 容诚会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0551-65397676 | ||||||||||||||||||||||||
| Fax No | 0551-65397675 | ||||||||||||||||||||||||
| Website | www.ahwbyy.cn | ||||||||||||||||||||||||
| wbyydmb@ahwbyy.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 25/09/2023 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 2.000 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.500 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 21.960 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 0.997B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |